Edition:
United Kingdom

MYnd Analytics Inc (MYND.OQ)

MYND.OQ on NASDAQ Stock Exchange Capital Market

2.57USD
22 Feb 2018
Change (% chg)

-- (--)
Prev Close
$2.57
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
3,709
52-wk High
$5.24
52-wk Low
$2.21

Chart for

About

MYnd Analytics, Inc., formerly CNS Response, Inc., is a predictive analytics company. The Company has developed a decision support tool to help physicians reduce trial and error treatment in mental health, and provide personalized care to patients. The Company provides objective clinical decision support to mental healthcare... (more)

Overall

Beta: 0.55
Market Cap(Mil.): $16.24
Shares Outstanding(Mil.): 4.24
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 28.42 16.60
EPS (TTM): -- -- --
ROI: -- 6.44 10.66
ROE: -- 10.09 14.30

BRIEF-MYnd Analytics Awarded Canadian Patent On Neuromodulation Platform Predicts Patients Likely To Respond To TMS For Treating Depression

* MYND ANALYTICS AWARDED CANADIAN PATENT ON NEUROMODULATION PLATFORM; PREDICTS PATIENTS LIKELY TO RESPOND TO TMS FOR TREATING DEPRESSION Source text for Eikon: Further company coverage:

08 Feb 2018

BRIEF-MYnd Analytics announces acquisition of Arcadian Telepsychiatry Services

* MYnd Analytics announces acquisition of Arcadian Telepsychiatry Services to expand AI & data analytics platform in telemedicine

14 Nov 2017

BRIEF-Mynd Analytics appoints Peter Unanue to board of directors

* Mynd Analytics appoints Peter Unanue to board of directors Source text for Eikon: Further company coverage:

20 Sep 2017

Earnings vs. Estimates